- Home
- Publications
- Publication Search
- Publication Details
Title
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 43
Publisher
MDPI AG
Online
2017-12-26
DOI
10.3390/ijms19010043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis
- (2017) Leila Sisic et al. Gastric Cancer
- Antiangiogenic Therapy in Gastroesophageal Cancer
- (2017) Zhaohui Jin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
- (2017) David Cunningham et al. LANCET ONCOLOGY
- The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma
- (2017) Leila Sisic et al. SURGICAL ONCOLOGY-OXFORD
- A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin1 predicts survival in patients with advanced gastric cancer
- (2017) Sedef Hande AKTAŞ et al. Turkish Journal Of Medical Sciences
- Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer
- (2017) Susanne Blank et al. Oncotarget
- Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer
- (2017) Yi Lin et al. Oncotarget
- Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
- (2017) Li-Tzong Chen et al. Cancer Research and Treatment
- Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?
- (2017) Filipa Macedo et al. Journal of Gastric Cancer
- Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
- (2016) Ulrich T Hacker et al. BRITISH JOURNAL OF CANCER
- Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials
- (2016) Fei Shan et al. CANCER LETTERS
- PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3K/Akt and p38MAPK pathways
- (2016) Hassan Akrami et al. CELL BIOCHEMISTRY AND FUNCTION
- Inhibitory effects of bevacizumab monoclonal antibodies in combination with chemotherapy in different time sequences on a human gastric carcinoma cell line
- (2016) Y. Lv et al. IRISH JOURNAL OF MEDICAL SCIENCE
- PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells
- (2016) Fatemeh Mahmoodi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
- (2016) Nick Pavlakis et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-218 suppresses gastric cancer cell proliferation and invasion via regulation of angiopoietin-2
- (2016) Sifeng Tang et al. Experimental and Therapeutic Medicine
- Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma
- (2015) Do Joong Park et al. ANNALS OF SURGICAL ONCOLOGY
- Association of angiogenic factors with prognosis in esophageal cancer
- (2015) Lena Dreikhausen et al. BMC CANCER
- Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis
- (2015) Zheng Chen et al. GUT
- Infiltrating Mast Cells Correlate with Angiogenesis in Bone Metastases from Gastric Cancer Patients
- (2015) Michele Ammendola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Angiogenic and growth factors in gastric cancer
- (2015) Susanne Blank et al. JOURNAL OF SURGICAL RESEARCH
- Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer
- (2015) Junxun Ma et al. MEDICINE
- HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a
- (2015) Qun Zhao et al. PLoS One
- IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer
- (2015) Xiaoqin Wu et al. TUMOR BIOLOGY
- Interleukin-8: A potent promoter of angiogenesis in gastric cancer
- (2015) JUN SHI et al. Oncology Letters
- Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer
- (2015) Christoph Kahlert et al. Oncotarget
- Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
- (2014) Lin Shen et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
- (2013) C Kahlert et al. BRITISH JOURNAL OF CANCER
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- Dll4-Notch signaling in regulation of tumor angiogenesis
- (2013) Zhaoguo Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Evaluation of Hypertension and Proteinuria as Markers of Efficacy in Antiangiogenic Therapy for Metastatic Colorectal Cancer
- (2013) Leila Khoja et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
- (2013) Jun-Eul Hwang et al. YONSEI MEDICAL JOURNAL
- Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer
- (2012) Tian-Bao WANG et al. Asia-Pacific Journal of Clinical Oncology
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer
- (2012) Pedro Villarejo-Campos et al. Clinical & Translational Oncology
- Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
- (2012) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors
- (2012) Alicia S Chung et al. JOURNAL OF PATHOLOGY
- Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients
- (2012) Esther Tahover et al. MEDICAL ONCOLOGY
- Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
- (2012) Harry D. Bear et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo
- (2012) PENG SUN et al. ONCOLOGY REPORTS
- Anticancer molecules targeting fibroblast growth factor receptors
- (2012) Guang Liang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Bevacizumab-Induced Hypertension
- (2011) Kostas N. Syrigos et al. BIODRUGS
- Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
- (2011) P Österlund et al. BRITISH JOURNAL OF CANCER
- Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
- (2011) Thomas Schmidt et al. CANCER CELL
- Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients
- (2011) Shogo Kikuchi et al. CANCER SCIENCE
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
- (2011) Benjamin Beck et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
- (2011) T. Schmidt et al. Hematology-American Society of Hematology Education Program
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- (2010) Sara Van de Veire et al. CELL
- Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours
- (2010) S. L. Sheng et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
- (2010) Nadine Rohwer et al. PLoS One
- Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker
- (2010) Emily S. Robinson et al. SEMINARS IN NEPHROLOGY
- Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model
- (2010) Takuya Imaizumi et al. SURGERY TODAY
- Preoperative Serum Angiopoietin-2 Levels Correlate with Lymph Node Status in Patients with Early Gastric Cancer
- (2009) Min Jung Jo et al. ANNALS OF SURGICAL ONCOLOGY
- High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer
- (2009) Ó. Vidal et al. BRITISH JOURNAL OF SURGERY
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- "Antimyeloangiogenic" Therapy for Cancer by Inhibiting PlGF
- (2009) S. Loges et al. CLINICAL CANCER RESEARCH
- Role and Therapeutic Potential of VEGF in the Nervous System
- (2009) Carmen Ruiz de Almodovar et al. PHYSIOLOGICAL REVIEWS
- Effects of angiopoietin-1 on attachment and metastasis ofhuman gastric cancer cell line BGC-823
- (2009) Xi-Long Ou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
- (2008) Sung Yong Oh et al. BMC CANCER
- STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
- (2008) Matthias Ernst et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of Bevacizumab, a Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, on Peritoneal Metastasis of MNK-45P Human Gastric Cancer in Mice
- (2008) Shigeo Ninomiya et al. JOURNAL OF SURGICAL RESEARCH
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search